Emerging Trends to Drive Diabetes Diagnostics Market Growth at 7.5% CAGR Through 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Diabetes Diagnostics Market Size Growth Forecast: What to Expect by 2025?
The sector dedicated to diabetes diagnostic solutions has demonstrated robust expansion lately, projecting an increase from its 2024 valuation of $25.39 billion to $27.31 billion by 2025, reflecting a compound annual growth rate of 7.6% throughout this period; this upward trajectory during the past years has been fueled by several factors, including the heightened incidence of diabetes across populations, an enlarging elderly demographic, the proliferation of inactive lifestyles, greater acceptance of less intrusive diagnostic methods, and the growing rates of obesity.

How Will the Diabetes Diagnostics Market Size Evolve and Grow by 2029?
The market dedicated to diabetes diagnostic solutions is projected to experience robust expansion in the near future, reaching a valuation of $36.42 billion by the year 2029, driven by a consistent compound annual growth rate of 7.5%. This upward trajectory throughout the forecast duration is fueled by several factors, notably the increased utilization of insulin delivery systems, continuous progress in diabetes-related technologies, a growing trend toward unhealthy lifestyle choices, the escalating incidence of both Type 1 and Type 2 diabetes, and the broadening scope of medical infrastructure. Key developments shaping the outlook for this period encompass breakthroughs in biosensor innovation, technological progress across the sector, improvements in diagnostic methodologies, the move toward tailored medical treatments, and the integration of sophisticated tools within in vitro diagnostic offerings.

View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

What Drivers Are Propelling the Growth of Diabetes Diagnostics Market Forward?
The increasing incidence of obesity is anticipated to be a major impetus for the expansion of the diabetes diagnostics sector in the forthcoming period. This excessive accumulation of body fat, which constitutes obesity, elevates vulnerability to numerous maladies, notable among them being cardiovascular ailments and diabetes. Factors such as a lack of physical movement, heightened intake of refined and energy-dense foodstuffs, hereditary tendencies, and insufficient exercise contribute significantly to the elevated rates of obesity observed globally. Diagnostic tools for diabetes become instrumental in managing obesity by facilitating the prompt detection of compromised glucose processing and insulin resistance, thus allowing for proactive measures to curb further weight gain and associated health deterioration. As an illustration, data from the US government entity, the Centers for Disease Control and Prevention, indicated that in 2022, twenty-two states exhibited adult obesity rates at or above 35 percent, which represents an uptick from the nineteen states reporting such figures in 2021. Consequently, this widespread obesity trend serves as a primary catalyst fueling the growth trajectory of the diabetes diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

Which Emerging Trends Are Transforming the Diabetes Diagnostics Market in 2025?
Leading firms within the diabetes diagnostics sector are concentrating efforts on pioneering new solutions, specifically tools for identifying gestational diabetes, as a strategy to broaden their offerings and cater to the escalating need for timely diagnosis and effective management of diabetes arising during pregnancy. A diagnostic instrument for gestational diabetes encompasses medical apparatus or procedures employed to identify and track this condition in expectant mothers, generally involving the assessment of blood sugar levels via methodologies like the oral glucose tolerance test (OGTT) to gauge sugar metabolism efficiency while pregnant. Illustratively, in August of 2024, DirectSens GmbH, an Austrian biotech entity, introduced the XpressGT RUO kit, a novel biosensor instrument engineered for detecting disorders linked to insulin resistance, including but not limited to gestational diabetes, endometriosiss, and hepatic ailments. This particular device delivers swift determinations by quantifying 2-hydroxybutyrate (2-HB) concentrations in venous blood samples and functions seamlessly with conventional laboratory analysis equipment, a breakthrough intended to facilitate earlier detection and potentially enhance results for a vast global patient population.

What Are the Key Segments in the Diabetes Diagnostics Market?
The diabetes diagnosticsmarket covered in this report is segmented -

1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types
2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes
3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users

Subsegments:
1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters
2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices
3) By Lancets: Single-use Lancets; Multi-use Lancets
4) By Test Strips: Standard Test Strips; Smart Test Strips
5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood ket*one Meters

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

Who Are the Key Players Shaping the Diabetes Diagnostics Market's Competitive Landscape?
Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.

What Geographic Markets Are Powering Growth in the Diabetes Diagnostics Market?
North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21167

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.